Purpose Salvage chemotherapy followed by high-dose therapy and autologous stem-cell
transplantation (ASCT) is the standard treatment for relapsed diffuse large B-cell lymphoma (…

Phase 2 studies suggest that the monoclonal antibody rituximab may improve the prognosis
of patients with follicular lymphoma (FL) when it is added to chemotherapy. In the current …

Background All-trans retinoic acid (ATRA) with chemotherapy is the standard of care for
acute promyelocytic leukemia (APL), resulting in cure rates exceeding 80%. Pilot studies of …

Background High-dose chemotherapy followed by transplantation of autologous haemopoietic
stem cells (BEAMHSCT) is frequently used to treat patients with relapsed Hodgkin's …

Background Cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) is used
to treat patients with non-Hodgkin lymphoma. Interval decrease from 3 weeks of treatment (…

Measurements of charged pion and kaon production in central Pb+ Pb collisions at 40, 80,
and 158 A GeV are presented. These are compared with data at lower and higher energies …

Cyclophosphamide, doxorubicin, vincristine, and prednisone, given every 3 weeks (CHOP-21),
is standard chemotherapy for aggressive lymphomas. To determine whether biweekly …

The Symptom Check-List-90-R (SCL-90-R) is a widely used psychological status symptom
inventory. The properties of the German SCL-90-R version were studied in two clinical …

Purpose The International Prognostic Index (IPI) is widely used for risk stratification of patients
with aggressive B-cell lymphoma. The introduction of rituximab has markedly improved …

Peripheral blood cells are increasingly used in place of bone marrow as a source of hematopoietic
stem cells for allogeneic transplantation. The relative efficacy of these 2 approaches …